医学
凝结
胃肠病学
内科学
肝病
羟基氯喹
部分凝血活酶时间
混凝试验
因子IX
外科
疾病
传染病(医学专业)
2019年冠状病毒病(COVID-19)
作者
George Chalkiadakis,Despina Kyriakou,Eleni Oekonomaki,John Tsiaoussis,Michael G. Alexandrakis,S Vasilakis,Elias Kouroumalis
标识
DOI:10.1111/j.1572-0241.1999.01317.x
摘要
Three patients with liver disease and prolonged activated partial thromboplastine time (APTT) on routine tests are presented. One woman had metastatic liver disease from gastric carcinoma, a second woman had autoimmune hepatitis, and one man had severe chronic hepatitis B. APTT was not corrected after mixing experiments with 25%, 50%, and 75% of normal pool plasma, indicating the presence of an acquired inhibitor. In all three cases, factor XII coagulant activity was reduced: <1%, <1%, and 3%, respectively, while all of the other coagulation factors were normal. In all three cases no other auto-antibody was detected. In the first patient, APTT was normalized after a left liver lobectomy, whereas the primary lesion remained unresected. In the second patient, the FXII activity was improved after corticosteroid therapy but never returned to normal values. In the third patient, the APTT was improved after hydroxychloroquine therapy. None of the patients had hemorrhagic or thrombotic phenomena.
科研通智能强力驱动
Strongly Powered by AbleSci AI